| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |